Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|February 6, 2019
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myelomaA Keith Stewart, Amrita Y Krishnan, Seema Singhal, et al.
Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Leukemia & Lymphoma|September 2, 2011
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemiaClemens-Martin Wendtner, Peter Hillmen, Daruka Mahadevan, et al.
Cancer Medicine|March 19, 2020
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practiceSameer A Parikh, Sara J Achenbach, Timothy G Call, et al.
Leukemia & Lymphoma|March 28, 2015
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myelomaRuben Niesvizky, Ashraf Z Badros, Luciano J Costa, et al.
The Lancet. Haematology|May 22, 2019
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validationsJacob D Soumerai, Ai Ni, Mohamed Darif, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2019
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic LeukemiaThomas J Kipps, Graeme Fraser, Steven E Coutre, et al.
Mayo Clinic Proceedings|March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted TherapyDavid Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Nature Medicine|November 15, 2016
IAP antagonists induce anti-tumor immunity in multiple myelomaMarta Chesi, Noweeda N Mirza, Victoria M Garbitt, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementing individualized medicine into the medical practiceKonstantinos N Lazaridis, Tammy M McAllister, Dusica Babovic-Vuksanovic, et al.
Pageof 9